Get started
T2 BIOSYSTEMS NEW DL-,001T2 BIOSYSTEMS NEW DL-,001T2 BIOSYSTEMS NEW DL-,001

T2 BIOSYSTEMS NEW DL-,001

No trades
See on Supercharts
Overview
Financials News Discussions Seasonals

3T2 chart


Full chart

3T2 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.63 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.753 EUR
Net income (FY)
‪−45.37 M‬ EUR
Revenue (FY)
‪6.52 M‬ EUR
Shares float
‪12.48 M‬
Beta (1Y)
0.09

Employees


Employees (FY)
113
Change (1Y)
−45 −28.48%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About T2 BIOSYSTEMS NEW DL-,001


Sector
Health Technology
Industry
Medical Specialties
CEO
John J. Sperzel
Website
t2biosystems.com
Headquarters
Lexington
Founded
2006
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

3T2 news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BER exchange T2 BIOSYSTEMS NEW DL-,001 stocks are traded under the ticker 3T2.
3T2 reached its all-time high on Jun 18, 2018 with the price of 424.000 EUR, and its all-time low was 0.056 EUR and was reached on Oct 13, 2022. View more price dynamics on 3T2 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track T2 BIOSYSTEMS NEW DL-,001 financials in yearly and quarterly reports right on TradingView.
T2 BIOSYSTEMS NEW DL-,001 is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
3T2 earnings for the last quarter are −0.51 EUR per share, whereas the estimation was −0.57 EUR resulting in a 10.94% surprise. The estimated earnings for the next quarter are −0.47 EUR per share. See more details about T2 BIOSYSTEMS NEW DL-,001 earnings.
T2 BIOSYSTEMS NEW DL-,001 revenue for the last quarter amounts to ‪1.78 M‬ EUR, despite the estimated figure of ‪2.56 M‬ EUR. In the next quarter, revenue is expected to reach ‪3.56 M‬ EUR.
3T2 net income for the last quarter is ‪−9.09 M‬ EUR, while the quarter before that showed ‪−8.37 M‬ EUR of net income which accounts for −8.59% change. Track more T2 BIOSYSTEMS NEW DL-,001 financial stats to get the full picture.
No, 3T2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 13, 2025, the company has 113.00 employees. See our rating of the largest employees — is T2 BIOSYSTEMS NEW DL-,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. T2 BIOSYSTEMS NEW DL-,001 EBITDA is ‪−37.18 M‬ EUR, and current EBITDA margin is −643.60%. See more stats in T2 BIOSYSTEMS NEW DL-,001 financial statements.
Like other stocks, 3T2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade T2 BIOSYSTEMS NEW DL-,001 stock right from TradingView charts — choose your broker and connect to your account.